-
The HPV Vaccine Prevents Cancer. Why Do Many Cancer Survivors Not Get It?A recent study investigated why some young cancer survivors did not want the HPV vaccine and how they can be better served.
by Pamela Rafalow Grossman
-
March 24: The Week in Cancer NewsDrug shortage affects patients with advanced prostate cancer, and military pilots and ground crews have increased cancer rates.
by Marci A. Landsmann
-
March 17: The Week in Cancer NewsActive monitoring a viable choice for some with prostate cancer, and cancer’s effects on women’s sexual activity not addressed by providers.
by Kevin McLaughlin
-
The Future of Cancer CareForum discusses next-generation technologies that will guide oncology research and patient care in the years to come.
by Thomas Celona
-
March 10: The Week in Cancer NewsThe FDA sets rule that requires mammography providers to notify women who have dense breasts, and the ‘Jimmy Carter effect’ on immunotherapy treatment.
by Eric Fitzsimmons
-
On Wearing a Brave Face for Myself and OthersA woman living with lung cancer reflects on the contrast between how people see her and how she feels as someone living with metastatic disease.
by Suzanne Adriana Remington
-
March 3: The Week in Cancer NewsExercising only 11 minutes per day can reduce your cancer risk, and new robotic technology helps detect early-stage lung cancer.
by Thomas Celona
-
Cervical Cancer Found at Later Stages After 65A study found women in California were more likely to have cervical cancer diagnoses at a later stage after age 65.
by Jon Kelvey
-
February 24: The Week in Cancer NewsAggressive end-of-life measures are common in people with advanced cancer in nursing homes, and findings suggest immune checkpoint inhibitors could one day be the preferred treatment in localized cancer.
by Marci A. Landsmann
-
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
